SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Zura Bio Limited (ZURA) has a negative trailing P/E of -5.3, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -18.79%.
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+162.2%).
- Trailing Earnings Yield -18.79% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
- Analyst consensus target $15.00 (+162.2% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 59/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ZURA
Valuation Multiples
P/E (TTM)-5.3
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio5.21
P/S Ratio0.00
EV/EBITDA-3.5
Per Share Data
EPS (TTM)$-1.06
Book Value / Share$1.08
Revenue / Share$0.00
FCF / Share$-0.69
Yields & Fair Value
Earnings Yield-18.79%
Dividend Yield0.00%
Analyst Target$15.00 (+162.2%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2022 |
14.8 |
0.00 |
0.96 |
0.00 |
- |
| 2022 |
-4.9 |
0.10 |
-3.90 |
0.00 |
- |
| 2023 |
-2.4 |
0.00 |
2.42 |
0.00 |
- |
| 2024 |
-3.6 |
0.05 |
1.28 |
0.00 |
- |
| 2025 |
-5.0 |
-0.06 |
4.86 |
0.00 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2021 |
$0.40 |
$0.00 |
$8.42M |
- |
| 2022 |
$0.21 |
$0.00 |
$3.55M |
- |
| 2023 |
$-2.09 |
$0.00 |
$-60.36M |
- |
| 2024 |
$-0.60 |
$0.00 |
$-45.39M |
- |
| 2025 |
$-1.06 |
$0.00 |
$-99.35M |
- |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$-0.67 |
$-0.88 – $-0.50 |
$8.33M |
$8.33M – $8.33M |
4 |
| 2027 |
$-0.62 |
$-1.04 – $-0.11 |
$10.71M |
$10.71M – $10.71M |
4 |
| 2028 |
$-0.85 |
$-1.31 – $-0.61 |
$8.33M |
$8.33M – $8.33M |
6 |
| 2029 |
$-1.09 |
$-1.09 – $-1.09 |
$16.67M |
$16.67M – $16.67M |
4 |
| 2030 |
$-0.69 |
$-0.69 – $-0.69 |
$186.16M |
$186.16M – $186.16M |
2 |
